Emerging World Pharma, Inc.

OTC: EWPI · Healthcare · Drug Manufacturers - Specialty & Generic

PublicHQ Sunyani, Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 50

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ market scale, listing tenure

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

—

as of 2026-08-03

Market cap

$11.9k

as of 2026-08-03

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Emerging World Pharma, Inc.’s financial profile?

Emerging World Pharma, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

CERo Therapeutics Holdings, Inc.——Virpax Pharmaceuticals, Inc.——Binovi Technologies Corp.——HEALTHeUNIVERSE, Inc.——Green Hygienics, Inc.——ChromoCure, Inc.——

Key facts

CEOTerry Agrivos

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersSunyani, null

ExchangeOTC: EWPI

Employees—

IPO date2000-03-29

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.